Stereotactic radiosurgery for brain metastases and the questionable role of whole-brain radiotherapy
In this exclusive webinar, Oncology Central Ambassador Arjun Sahgal from Sunnybrook Health Sciences Centre (ON, Canada) discusses future directions of brain metastasis treatment, including key indications for the use of radiosurgery, the toxicities and adverse effects associated with whole-brain radiation, and future applications for radiosurgery.
The current evidence is supporting stereotactic radiosurgery alone for patients with limited brain metastases. Future directions include radiosurgery for other indications traditionally considered for whole-brain radiation. The aim of this presentation is to provide a current viewpoint on the role of radiosurgery and whole-brain radiation for patients with brain metastases.
What will you learn?
- Indications for radiosurgery
- The toxicities of whole-brain radiation
- Future applications of radiosurgery
Who may this interest?
- Medical Oncologists
- Surgical Oncologists
- Radiation Oncologists
- Oncology Nursing
- Radiation Therapists
- Medical Physicists
Arjun Sahgal focuses his research on spinal metastases, brain metastases and primary CNS tumors. He aims to further our understanding of the application of radiotherapy for these diseases, and to develop new therapeutic strategies relating to the application of high precision radiotherapy technology.
His primary research area is in technical evaluation and clinical trials specific to stereotactic body radiotherapy of spinal tumors. In line with high precision treatments, Dr Sahgal participates in the development of non-radiotherapeutic modalities for spine and brain tumors using photodynamic therapy and MRI-guided ultrasound technology, respectively.